Botanical Solution, Inc. Secures Additional $7 Million, Totaling Over $13 Million in Series A Funding

DAVIS, Calif.–(BUSINESS WIRE)–BSI Secures $7 million, totaling over $13 million in Series A funding for development of QS-21 vaccine adjuvant and Quillibrium biofungicide roll out.
Click here to view original post